Max Rosett
Chief Financial Officer at Immunome Inc. (IMNM) since October 2023
Max Rosett has filed 9 insider reports with the SEC since October 2023, as chief Financial Officer at Immunome Inc. (IMNM). In the last 12 months Max Rosett sold $2.52M of stock on the open market. The latest filing, on July 27, 2026, reports grant or award at Immunome Inc. (IMNM).
- Filings
- 9
- Companies
- 1
- Bought on market
- None
- Sold on market
- $2.75M
Companies where Max Rosett is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officersince October 2023 | 101,287 | $2.75M | $18.70 | Jul 27, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 23, 2026IMNMChief Financial Officer Rosett Max was granted 47,250 shares, increasing direct ownership by 87% to 101,287 unitsForm 4Grant or award
- Jun 15, 2026-$1.09MIMNMChief Financial Officer Rosett Max sold $1,093,800 worth of shares (60,000 units at $18.23) as part of a pre-agreed trading plan and exercised 60,000 shares at a strike of $1.05Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 2, 2026-$1.42MIMNMSEC Form 4 filed by Rosett MaxForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 29, 2025IMNMSEC Form 4 filed by Chief Financial Officer Rosett MaxForm 4Grant or award
- Sep 19, 2024-$230KIMNMChief Financial Officer Rosett Max exercised 42,000 shares at a strike of $1.05 and sold $230,224 worth of shares (14,380 units at $16.01), increasing direct ownership by 139% to 47,476 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Aug 9, 2024IMNMSEC Form 4 filed by EVP, Operations & CFO Rosett MaxForm 4Grant or award
- May 16, 2024IMNMSEC Form 4 filed by Rosett MaxForm 4Grant or award
- Jan 31, 2024IMNMSEC Form 4 filed by Rosett MaxForm 4Grant or award
- Oct 2, 2023IMNMNew insider Rosett Max claimed ownership of 19,856 sharesForm 3New insider
Compare Max Rosett with
- Max Rosett vs Jack Higgins1 shared
- Max Rosett vs Isaac Barchas1 shared
- Max Rosett vs Kinney Horn1 shared
- Max Rosett vs Philip Tsai1 shared
- Max Rosett vs Sandra G. Stoneman1 shared
- Max Rosett vs Clay B Siegall1 shared
Other insiders at the same companies
- Jack HigginsIMNM
- Isaac BarchasIMNM
- Kinney HornIMNM
- Philip TsaiIMNM
- Sandra G. StonemanIMNM
- Robert LechleiderIMNM
- Clay B SiegallIMNM
- Sandra M SwainIMNM
- Philip WagenheimIMNM
- Jean Jacques BienaimeIMNM
- James P BoylanIMNM
- Carol SchaferIMNM
Questions about Max Rosett
- What is Max Rosett's role at Immunome Inc.?
- Max Rosett reports to the SEC as chief Financial Officer at Immunome Inc. (IMNM), according to the latest filing on July 27, 2026.
- How many shares does Max Rosett own?
- After the latest filing that states it, Max Rosett directly owned 101,287 shares of Immunome Inc. (IMNM). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Max Rosett bought or sold stock recently?
- The most recent open-market sale was on June 15, 2026: sold 60,000 shares of Immunome Inc. (IMNM) for $1.09M at an average of $18.23.
- How do I get alerts when Max Rosett files?
- Follow Max Rosett on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Max Rosett (SEC CIK 0001994071). Totals count each trade once, skipping amendments whose original is on file, from Oct 12, 2023 on. View on SEC EDGAR